Neogen reported $2.1B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Agilent USD 6.74B 371M Sep/2025
Avanos Medical USD 778M 1.7M Sep/2025
Bio-Rad Laboratories USD 6.74B 391.9M Sep/2025
Danaher USD 52.53B 1.46B Dec/2025
Idexx Laboratories USD 1.56B 5.97B Sep/2025
Illumina USD 2.38B 123M Sep/2025
Integra LifeSciences USD 1.04B 1.09M Sep/2025
Neogen USD 2.1B 14.16M Sep/2025
Quidel USD 2.04B 756.3M Sep/2025
STAAR Surgical USD 353.78M 17.21M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Zoetis USD 5.4B 421M Sep/2025